Alexza Pharmaceuticals Inc (NASDAQ:ALXA)

CAPS Rating: 4 out of 5

An emerging pharmaceutical company focused on the development and commercialization of novel, proprietary products for the treatment of acute and intermittent conditions.

Recs

0
Player Avatar nizzer (26.76) Submitted: 6/22/2011 9:36:50 AM : Outperform Start Price: $1.58 ALXA Score: -79.13

Upcoming catalysts that will provide a high run up before pdufa. Between the upcoming rally, the potential of az-004, and their drug delivery technology this can be a multi-bagger by the end of the year and in the long term/

Featured Broker Partners


Advertisement